HKScan’s FY 2012 - Analysts’ consensus EPS €0,16 is reasonable
HKScan’s 2012 financial statement will be released on February and now is the right time to look at what analysts have thought about HKScan's earnings for the year 2012.
Bloomberg brings together analysts' forecasts and
other company information and HKScan’s forecasts are also available. The consensus FY 2012 EPS (pre-exceptional) is
€0,16. The number of participating analysts is 8. Hovering over the chart, one can find that
the estimates range from €0,12 to €0,19.
That’s nice. The not so nice
thing is that the page says the estimates to be in U.S. dollars. The chart, however, strongly suggests that
the estimates are in euros, like many but not all monetary amounts on the page. For instance, HKScan’s actual 2011 EPS really
was €0,18 as the chart on the page also says.
What is required for the FY 2012 EPS to be €0.16?
Due to the weak H1, EPS after Q3 is only €0,01. The Q4 EPS must therefore be € 0,15. Incidentally in 2011 the Q4 EPS was € 0.14
and in 2010 the Q4 EPS was €0,15. So it
seems that analysts on average expect roughly the same Q4 result as it was in
the preceding two years. Now, let’s look
at actual quarterly EBITs from recent years.
The chart below illustrates HKScan’s quarterly EBITs starting from
2009. The readings are highly unofficial
and possible errors are all mine. Actual
EBITs are marked with solid lines.
Dashed circles show a set of reasonable market-specific Q4 figures, which
could ensure the realization of the analysts’ consensus. Please note that Group
administration costs, they may be some €2 million, are subtracted from the
whole HKSscan Group’s result.
The case looks simple. In order to reach the FY 2012 consensus EPS, the entire Group's Q4 EBIT should be approximately €19 million. First adding the share of associates' results perhaps some €0,5 million, then subtracting net financial expenses perhaps about €8 million, then continuing guesswork and subtracting taxes about €2 million and finally subtracting profit attributable to non-controlling interests, perhaps about €1 million, we end up with the sum of €8,5 million. The number of shares is approximately 55 million. Then, Q4 EPS would be about €0,15, which is exactly as required for the FY 2012 consensus EPS €0,16 to be achieved. Please remember, that EPS after Q3 is already €0,01. In all, the consensus does not look particularly unrealistic. Let's look at each of the market area.
The case looks simple. In order to reach the FY 2012 consensus EPS, the entire Group's Q4 EBIT should be approximately €19 million. First adding the share of associates' results perhaps some €0,5 million, then subtracting net financial expenses perhaps about €8 million, then continuing guesswork and subtracting taxes about €2 million and finally subtracting profit attributable to non-controlling interests, perhaps about €1 million, we end up with the sum of €8,5 million. The number of shares is approximately 55 million. Then, Q4 EPS would be about €0,15, which is exactly as required for the FY 2012 consensus EPS €0,16 to be achieved. Please remember, that EPS after Q3 is already €0,01. In all, the consensus does not look particularly unrealistic. Let's look at each of the market area.
HKScan Finland
In Finland,
HKScan needs to reach a moderately good Q4 result, preferably better than those
achieved in recent years. Such a result
is not a cakewalk. The 2011 Q4 EBIT was
a little over 7 million and in the 2011 financial statement it was considered a
good result. In particular, the company
stated that the Christmas season 2011 succeeded thanks to the newly launched
rapeseed pork ham. On this season no
major new products were in the product range.
However, as the chart also tells, 2012 quarters Q1 to Q3 have gone
better when compared to the previous year.
Therefore, a modest improvement also in Q4 is well possible. Then Q4 EBIT
of 8 million is achievable.
HKScan Sweden
As HKScan has repeatedly stated,
the HKScan Sweden’s weak performance
may lower the whole Group's annual result below FY 2011 level. Especially H1 was insanely bad. Then, one cannot expect any super Q4. However, it should also be noted, that the
2011 Q4 EBIT, slightly more than € 7 million, was specifically not considered a
good result, and according to the company, the Christmas season 2011 was quieter
than expected. Now the things could be changed. It is precisely because there was now a new season
product, rapeseed ham, the same product which was a success in Finland already
in 2011. Then Q4 EBIT of € 6 million, slightly lower than in 2011, does not sound impossible.
HKScan
Denmark
In Denmark the Q4
2012 result should be better than the corresponding result in 2011. There were clear reasons for 2011 Q4's
disappointing result. One of them was the
clearing of export stocks of chicken leg quarters, as mentioned in the 2011 financial statement release. Moreover, production in Vinderup has
been restarted in early December. Then
Q4 EBIT of €1 million is within the
realms of possibility. In addition, a
non-recurring income of fire insurance compensation is possible, as the company
itself has said
HKScan Baltics
HKScan Baltics
is in a good shape and one can expect a good Q4 result, something similar to Q4
2011. It is true, that the Q4 2011 was a
success and Christmas season sales went well, but the last Christmas was a
success as well. Both Tallegg and
Rakvere Lihakombinaat sales were up in many important product groups. Then Q4 EBIT
of € 3 million is undoubtedly possible.
HKScan Poland
HKScan Poland’s
Q4 2012 may have been worse than the previous year’s corresponding period, even
though all the first three quarters in 2012 have been better when compared to the
previous year. In 2011 December sales reached all-time high. Perhaps now Sokołów has failed to reach the
same. Boguslaw Miszczuk, president of
Sokołów, in a journal article points out a rather pessimistic view, something
like this:
The deteriorating economic situation in Poland may limit the consumption of foods, including meat and dairy products – it may be expected that consumers are increasingly interested in lower-priced products.
The deteriorating economic situation in Poland may limit the consumption of foods, including meat and dairy products – it may be expected that consumers are increasingly interested in lower-priced products.
Miszczuk’s statement refers to the current year but
one may suppose that the last quarter of 2012 did not go to the most optimal
way. It is possible that the demand has
shifted to private label brands and
cheaper product groups. Exports could still go well, even if the zloty was
stronger compared to Q4 2011. Then Q4 EBIT of €3 million, somewhat
lower than in 2011, is thinkable.
What else?
As already mentioned, analyst’s FY 2012 EPS estimates range from €0,12 to €0,19. They all are decent, if they are compared to recent years’ results. However, compared to the company's targets, they all sound only trashy.
HKScan's top management always emphasizes the
company's strong market position in all its market areas. Unfortunately it just
has not been reflected in the company's success in Finland and Sweden. Positively
thinking, the company has tremendous potential.
In the best case, HKScan’s earnings in Finland and Sweden will improve dramatically
within only a few years. In the slightly longer term Poland, with its population
of 40 million, may bring almost half of the profits, despite the fact that
HKScan's share of Sokołów is only 50%. EBIT
readings may then be on a totally different level than today. We’ll see.
Perhaps the success comes tomorrow, but today the most
striking feature is the fact that HKScan has a huge pile of debt. Consequently,
the company is burdened by enormous financial expenses. It is almost senseless,
that (now ignoring financial income) for example in 2011 HKScan financial
expenses were €38,3 million and at the same time EBIT was only slightly more, €39,6
million.
We will discuss HKScan later but on
Friday, February 15th, we
are going to look at Atria’s Q4 2012. Midday is no longer as dim as it could be, but I
believe that summer will not come prior to spring.
This is Artoparto and here is my Disclaimer. Please read it.
Disclaimer:
All content provided on this site is for entertainment purposes
only. This site does not provide any
investment advice and content on this site should not be construed as
recommendation to buy or sell any financial instruments. Please consult a qualified financial adviser
before making any financial decision. I
make no representations as to the accuracy, completeness, suitability, or
validity, of any information on this site or found by following any link on
this site. I will not be liable for any
errors, omissions, or any losses, injuries, or damages arising from displaying
or using any content provided on this site.
I am not responsible for users' comments. I reserve the right to update or delete any
content on this site for any reason.
No comments:
Post a Comment